NCT02376127View on ClinicalTrials.gov

Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

February 24, 2015

Primary Completion Date

July 16, 2025

Study Completion Date

July 16, 2025

Conditions
Solid CancerMetastatic Spinal Lesions
Interventions
PROCEDURE

Dynamic contrast enhancement MRI

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER